MB Clinical Research and Consulting LLC

For profitWebsite ↗

Also known as: MB Clinical Research and Consulting | MB Clinical Research and Consulting LLC | MB Clinical Research & Consulting | MB Clinical Research & Consulting, LLC | MB Clinical Research, LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

May 1, 2016

Last known activity

Sep 9, 2025

Timeline

2010s

Jan 1, 2013
MB Clinical Research and Consulting LLC— Founded

Drugs by trial phase (15 distinct, 11 trials)

Phase 4 (3 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Other trials (10 own, 0 via acquisition)

Indications

Studied for

Hypertriglyceridemia

Recent trials (15)

NCT06982508CollaboratorPhase 2Sep 9, 2025
NCT06012669Study directorN/ASep 6, 2023
NCT06012669OfficialN/ASep 6, 2023
NCT05540405OfficialN/AJan 31, 2023
NCT05540405Study directorN/AJan 31, 2023
NCT05456477Study directorN/AOct 7, 2022
NCT05438173Study directorN/AJul 11, 2022
NCT05438173OfficialN/AJul 11, 2022
NCT05287906Study directorN/AApr 15, 2022
NCT04177680Study directorPhase 2Feb 29, 2020
NCT04177680CollaboratorPhase 2Feb 29, 2020
NCT03443076Study directorPhase 4Feb 16, 2018
NCT03126981Study directorN/AApr 20, 2017
NCT03118583Study directorN/AMar 15, 2017
NCT03061409CollaboratorN/AMay 1, 2016

Details

Founded: Addison, IL, US Jan 1, 2013
Last known activity: Sep 9, 2025